Key facts
- This page summarizes John P. Saharek's Form 4 filing for HARROW, INC. (HROW).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Sep 2024, 17:26.
John P. Saharek - 11 Sep 2024 Form 4 Insider Report for HARROW, INC. (HROW)
- Reporting relationship
- CEO of ImprimisRx
- Issuer ticker
- HROW
- Reported as of
- 11 Sep 2024
- Net transaction value
- -$1,204,142
- SEC form
- 4
- Accepted by SEC
- 13 Sep 2024, 17:26:19 UTC
- Prior SEC filing
- 06 Mar 2024
- Next SEC filing
- 07 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John P. Saharek
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John P. Saharek filed Form 4 for HARROW, INC. (HROW) on 13 Sep 2024.
Change
- Previous filing in this sequence was filed on 06 Mar 2024.
- Current net transaction value: -$1,204,142.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HROW
transaction
Common stock
Options Exercise
- Transaction value
- $663,300
- Shares
- +90,000
- Change %
- +35%
- Price
- $7.37
- Shares after
- 344,803
- Date
- 11 Sep 2024
- Ownership
- Direct
HROW
transaction
Common stock
Tax liability
- Transaction value
- $1,867,442
- Shares
- -45,140
- Change %
- -13%
- Price
- $41.37
- Shares after
- 299,663
- Date
- 11 Sep 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HROW
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -90,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 90,000
- Exercise price
- $7.37
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option was granted on February 1, 2015 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of February 1, 2025. 29,107 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident and 16,033 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's cost to purchase the stock option.